This PDF is the current document as it appeared on Public Inspection on 07/17/2013 at 08:45 am.
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Muscular Dystrophy Coordinating Committee (MDCC).
The meeting will be open to the public and accessible by live webcast.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Type of Meeting: Open Meeting.
Date: August 26, 2013.
Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*—Approximate end time.
Agenda: The purpose of this meeting is to bring together the committee members to update one another on individual agency efforts, to discuss planning for revision of the Action Plan for the Muscular Dystrophies, and to discuss two issues affecting all types of muscular dystrophy: (a) Transitions to adulthood, career, and independence for individuals with muscular dystrophy and (b) therapeutic misconception in clinical trials.
An agenda is posted to the MDCC Web site: http://www.ninds.nih.gov/find_people/groups/mdcc/index.htm.
Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/2013_MDCC_Meeting/.
Webcast Live: For those not able to attend in person, this meeting will be webcast at: http://videocast.nih.gov/.
Place: Neuroscience Center, 6001 Executive Boulevard, Conference Room A1/A2, Rockville, Maryland 20852-1699.
Contact Person: John D. Porter, Ph.D., Executive Secretary, Muscular Dystrophy Coordinating Committee, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, NSC 2172, Bethesda, MD 20892, (301) 496-5739, firstname.lastname@example.org.
Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Attendance is limited to seating space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the Contact Person listed below in advance of the meeting.
All visitors must go through a security check at the Lobby of the Neuroscience Center (NSC) building to receive a visitor's badge. A government issued photo ID is required.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)Start Signature
Dated: July 11, 2013.
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-17188 Filed 7-17-13; 8:45 am]
BILLING CODE 4140-01-P